Drugs Made in America Acquisition CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D: Sponsor and CEO Disclose 12.5% Stake in Drugs Made In America Acquisition Corp. via Schedule 13D Filing
Drugs Made In America Acquisition LLC and its managing member, Lynn Stockwell, have filed a Schedule 13D disclosing a 12.5% beneficial ownership stake in Drugs Made In America Acquisition Corp., totaling 4,188,780 ordinary shares.